In one paragraphArticle in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
15 authors.
Seth M BloomRagon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, Massachusetts, USA.ORCID 0000-0002-0462-4596 Laura SymulInstitute of Statistics, Biostatistics and Actuarial Sciences (ISBA), Louvain Institute of Data Analysis and Modelling (LIDAM), UCLouvain, Belgium.ORCID 0000-0001-9286-0590 Joseph ElsherbiniRagon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, Massachusetts, USA.
Salina HussainRagon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, Massachusetts, USA.ORCID 0009-0005-6166-4358 Johnathan ShihRagon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, Massachusetts, USA.
Ashley SangoRagon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, Massachusetts, USA.
Caroline M MitchellRagon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, Massachusetts, USA.ORCID 0000-0001-9924-2349 Anke HemmerlingDepartment of Obstetrics, Gynecology, & Reproductive Sciences, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-6472-4804 Thomas P ParksOsel, Inc., Mountain View, California, USA.
Aditi KannanRagon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, Massachusetts, USA.ORCID 0009-0002-3347-1071 Fatima A HussainRagon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, Massachusetts, USA.
Craig R CohenDepartment of Obstetrics, Gynecology, & Reproductive Sciences, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0001-8654-6634 Douglas S KwonRagon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, Massachusetts, USA.ORCID 0000-0001-8521-8735 Funding
Mechanistic characterization of vaginal microbiome-metabolome associations and metabolite-mediated host inflammationK08AI171166 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI SETH MICHAEL BLOOM · 2023 to 2026
$729kGates Foundation INV-033690NIAID NIH HHS K08 AI171166
6 · The paper itselfAbstract
Bacterial vaginosis (BV) affects >25% of women worldwide and often recurs after standard-of-care metronidazole (MTZ) treatment. LACTIN-V, a live biotherapeutic product (LBP) containing
Identifiers
PMID40901072
PMCPMC12393677
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390